183 related articles for article (PubMed ID: 18931027)
1. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.
Ye Y; Lin Y; Manickavasagam S; Perez-Polo JR; Tieu BC; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2436-46. PubMed ID: 18931027
[TBL] [Abstract][Full Text] [Related]
2. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
[TBL] [Abstract][Full Text] [Related]
3. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
Ye Y; Lin Y; Atar S; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1158-69. PubMed ID: 16603698
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.
Birnbaum Y; Long B; Qian J; Perez-Polo JR; Ye Y
Basic Res Cardiol; 2011 May; 106(3):431-46. PubMed ID: 21360043
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.
Birnbaum Y; Ye Y; Rosanio S; Tavackoli S; Hu ZY; Schwarz ER; Uretsky BF
Cardiovasc Res; 2005 Feb; 65(2):345-55. PubMed ID: 15639473
[TBL] [Abstract][Full Text] [Related]
6. Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size.
Ye Y; Keyes KT; Zhang CF; Perez-Polo JR; Lin Y; Birnbaum Y
Cardiovasc Drugs Ther; 2010 Apr; 24(2):107-20. PubMed ID: 20379769
[TBL] [Abstract][Full Text] [Related]
7. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
[TBL] [Abstract][Full Text] [Related]
8. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.
Yasuda S; Kobayashi H; Iwasa M; Kawamura I; Sumi S; Narentuoya B; Yamaki T; Ushikoshi H; Nishigaki K; Nagashima K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1558-65. PubMed ID: 19286954
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase (NOS3) knockout decreases NOS2 induction, limiting hyperoxygenation and conferring protection in the postischemic heart.
Zhao X; Chen YR; He G; Zhang A; Druhan LJ; Strauch AR; Zweier JL
Am J Physiol Heart Circ Physiol; 2007 Mar; 292(3):H1541-50. PubMed ID: 17114245
[TBL] [Abstract][Full Text] [Related]
10. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
11. eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex.
Talukder MA; Yang F; Shimokawa H; Zweier JL
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H437-45. PubMed ID: 20525875
[TBL] [Abstract][Full Text] [Related]
12. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.
Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y
J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
14. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
Matsuhisa S; Otani H; Okazaki T; Yamashita K; Akita Y; Sato D; Moriguchi A; Imamura H; Iwasaka T
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2473-9. PubMed ID: 18390819
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
17. The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.
Ye Y; Keyes KT; Zhang C; Perez-Polo JR; Lin Y; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1454-65. PubMed ID: 20207816
[TBL] [Abstract][Full Text] [Related]
18. Disturbance effects of PM₁₀ on iNOS and eNOS mRNA expression levels and antioxidant activity induced by ischemia-reperfusion injury in isolated rat heart: protective role of vanillic acid.
Dianat M; Radmanesh E; Badavi M; Mard SA; Goudarzi G
Environ Sci Pollut Res Int; 2016 Mar; 23(6):5154-65. PubMed ID: 26552794
[TBL] [Abstract][Full Text] [Related]
19. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70.
Yin C; Salloum FN; Kukreja RC
Circ Res; 2009 Mar; 104(5):572-5. PubMed ID: 19213952
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.
Li XD; Yang YJ; Geng YJ; Zhao JL; Zhang HT; Cheng YT; Wu YL
Acta Pharmacol Sin; 2012 Jul; 33(7):879-87. PubMed ID: 22659627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
